Bio Protocol vs Maverick Protocol — how do they compare? Bio Protocol trades at Rp441.66 (market cap Rp1T, Rp164,61M 24h volume), while Maverick Protocol trades at Rp158.76 (market cap Rp185,64M, Rp57,47M 24h volume). The key difference: Bio Protocol is far larger — about 5386.8× Maverick Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1,2B / 2B MAV (59%) for Maverick Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Maverick Protocol for 25 Days on average.
| BIO | MAV | |
|---|---|---|
Market Cap | Rp1T | Rp185,64M |
Volume (24h) | Rp164,61M | Rp57,47M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,2B / 2B MAV (59%) |
Typical Hold Time | 18 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Maverick Protocol (MAV) is trading at Rp158.89 with a market cap of Rp185.72M, showing a bullish overall technical signal. The current price is near the pivot point of Rp159, with oscillators indicating strength but moving averages suggesting caution. Token circulation is at 59%, with a relatively short average hold time of 25 days, reflecting active trading. Recent news appears unrelated to the crypto project, indicating a need for verified protocol updates.
The outlook is cautiously optimistic due to bullish oscillators and proximity to resistance, but risks include low liquidity, potential misidentified news, and bearish moving averages. Key opportunities lie in breaking above Rp165 resistance, while major risks involve volatility from thin trading volumes and lack of recent fundamental developments for the token.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Maverick Protocol is a DeFi infrastructure provider focused on enhancing industry efficiency, powered by Maverick AMM. Maverick is backed by Founders Fund, Pantera Capital, Coinbase Ventures, Binance Labs, Circle Ventures, Gemini, etc. Maverick is eliminating inefficiency from DeFi by helping users put their liquidity where it can do the most work, hence providing smoother and more efficient transactions. This addresses some of the liquidity challenges that have historically troubled the DeFi space.
Read more on MAV →